Events

Explore the dynamic world of ARMI | BioFabUSA Events, where innovation in regenerative medicine takes center stage, propelling the United States’ bioeconomy forward and reshaping healthcare solutions across the nation. Rooted in our mission as a member-driven nonprofit organization, ARMI is at the forefront of revolutionizing manufacturing, healthcare, and education & workforce development.

BioFabUSA, the heartbeat of our organization, fosters collaboration among an extensive network of over 170 members, encompassing companies and academic institutions alike. Through a series of dynamic national and regional events, we not only host and collaborate but also passionately participate in gatherings that unite minds, ignite knowledge sharing, and pave the way for transformative advancements.

Should you aspire to share your insights, please consider submitting a speaker submission form. For any inquiries, feel free to reach out to us at events@armiusa.org. We look forward your involvement within our vibrant community.

2024 Leadership Advisory Council (LAC) Elections

Online Voting

Tier 3 LAC Bios_updatedThe Leadership Advisory Council (LAC) is a vital component of the ARMI|BioFabUSA Membership structure. Its responsibilities encompass advising the Board of Directors and Stakeholder Council, as appropriate, […]

Advanced Therapies Week 2024

Miami Convention Center 1901 Convention Center Drive, Miami Beach, FL, United States

Join ARMI | BioFabUSA at ATW 2024: Where the unpredictable moments forge the most powerful connections!

2024 Meeting in the Millyard

ARMI Campus 400 Commercial Street, Manchester, United States

Welcome to the 2024 Meeting in the Millyard (MITM) – A New American Industry!

BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.

Technology

ARMI

Initiatives

Learn more about work underway to build the biofabrication ecosystem and accelerate the science of regenerative medicine.